133 related articles for article (PubMed ID: 38446626)
1. VigiBase Pharmacovigilance Studies on Antidepressant-Related Adverse Reactions: A Scoping Review.
Kverno K
J Psychosoc Nurs Ment Health Serv; 2024 Mar; 62(3):7-10. PubMed ID: 38446626
[TBL] [Abstract][Full Text] [Related]
2. Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature.
Sartori D; Aronson JK; Onakpoya IJ
Syst Rev; 2020 Aug; 9(1):180. PubMed ID: 32791982
[TBL] [Abstract][Full Text] [Related]
3. Adverse drug reactions and their fatal outcomes in clozapine patients in VigiBase: Comparing the top four reporting countries (US, UK, Canada and Australia).
De Las Cuevas C; Sanz EJ; de Leon J
Schizophr Res; 2024 Jun; 268():165-174. PubMed ID: 37301669
[TBL] [Abstract][Full Text] [Related]
4. Clozapine-induced myocarditis in children and adolescents: a pharmacovigilance study using VigiBase and a systematic literature review.
De Las Cuevas C; Arrojo-Romero M; Ruan CJ; Schoretsanitis G; Sanz EJ; de Leon J
Expert Opin Drug Metab Toxicol; 2022 Nov; 18(11):715-727. PubMed ID: 36526610
[TBL] [Abstract][Full Text] [Related]
5. Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.
Watson S; Chandler RE; Taavola H; Härmark L; Grundmark B; Zekarias A; Star K; van Hunsel F
Drug Saf; 2018 Feb; 41(2):203-212. PubMed ID: 28933055
[TBL] [Abstract][Full Text] [Related]
6. Association between myocarditis and antipsychotics other than clozapine: a systematic literature review and a pharmacovigilance study using VigiBase.
De Las Cuevas C; Sanz EJ; Rohde C; de Leon J
Expert Rev Clin Pharmacol; 2022 Jan; 15(1):65-78. PubMed ID: 35062840
[TBL] [Abstract][Full Text] [Related]
7. An expert review of clozapine in Latin American countries: Use, monitoring, and pharmacovigilance.
Baptista T; Motuca M; Serrano A; Perez Lo Presti A; Fernandez-Arana A; Olmos I; Pabon A; Yepez JGA; Alejo Galarza GJ; Rivera Ramirez NM; Elkis H; Sanz EJ; De Las Cuevas C; de Leon J
Schizophr Res; 2024 Jun; 268():60-65. PubMed ID: 37985318
[TBL] [Abstract][Full Text] [Related]
8. Respiratory aspiration during treatment with clozapine and other antipsychotics: a literature search and a pharmacovigilance study in vigibase.
De Las Cuevas C; Sanz EJ; Villasante-Tezanos AG; de Leon J
Expert Opin Drug Metab Toxicol; 2023 Feb; 19(2):57-74. PubMed ID: 36920343
[TBL] [Abstract][Full Text] [Related]
9. Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK.
De Las Cuevas C; Sanz EJ; Gross JA; Correll CU; Verdoux H; Lally J; de Filippis R; Schulte PFJ; Molden E; Arrojo-Romero M; Bostrom AD; Schoretsanitis G; Fernandez-Egea E; de Leon J
Schizophr Res; 2024 Jun; 268():175-188. PubMed ID: 38065799
[TBL] [Abstract][Full Text] [Related]
10. Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: Focus on reports from various countries.
De Las Cuevas C; Sanz EJ; Ruan CJ; de Leon J
Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(4):238-250. PubMed ID: 36513400
[TBL] [Abstract][Full Text] [Related]
11. Adverse Drug Reactions Reported With Cholinesterase Inhibitors: An Analysis of 16 Years of Individual Case Safety Reports From VigiBase.
Kröger E; Mouls M; Wilchesky M; Berkers M; Carmichael PH; van Marum R; Souverein P; Egberts T; Laroche ML
Ann Pharmacother; 2015 Nov; 49(11):1197-206. PubMed ID: 26324356
[TBL] [Abstract][Full Text] [Related]
12. Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®.
Svendsen K; Wood M; Olsson E; Nordeng H
Eur J Clin Pharmacol; 2018 May; 74(5):627-636. PubMed ID: 29290074
[TBL] [Abstract][Full Text] [Related]
13. Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase
Dernoncourt A; Liabeuf S; Bennis Y; Masmoudi K; Bodeau S; Laville S; Hurtel-Lemaire AS; Gras-Champel V; Batteux B
BioDrugs; 2023 Jan; 37(1):73-87. PubMed ID: 36401769
[TBL] [Abstract][Full Text] [Related]
14. Adverse drug reactions in Nigerian children: a retrospective review of reports submitted to the Nigerian Pharmacovigilance Centre from 2005 to 2012.
Obebi Cliff-Eribo K; Sammons H; Star K; Ralph Edwards I; Osakwe A; Choonara I
Paediatr Int Child Health; 2016 Nov; 36(4):300-304. PubMed ID: 26384567
[TBL] [Abstract][Full Text] [Related]
15. An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance.
Sagud M; Breznoscakova D; Celofiga A; Chihai J; Chkonia E; Ristic Ignjatovic D; Injac Stevovic L; Kopecek M; Kurvits K; Kuzo N; Lazáry J; Mazaliauskienė R; Mladina Perisa D; Novotni A; Panov G; Pikirenia U; Rădulescu FȘ; Sukiasyan SG; Taube M; Tomori S; Wilkowska A; De Las Cuevas C; Sanz EJ; de Leon J
Schizophr Res; 2024 Jun; 268():53-59. PubMed ID: 37783650
[TBL] [Abstract][Full Text] [Related]
16. Safety of clozapine use during pregnancy: Analysis of international pharmacovigilance data.
Beex-Oosterhuis MM; Samb A; Heerdink ER; Souverein PC; Van Gool AR; Meyboom RHB; van Marum RJ
Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):725-735. PubMed ID: 32378285
[TBL] [Abstract][Full Text] [Related]
17. Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports.
Conte C; Rousseau V; Vert C; Montastruc F; Montastruc JL; Durrieu G; Olivier P
Fundam Clin Pharmacol; 2020 Aug; 34(4):518-520. PubMed ID: 32022302
[TBL] [Abstract][Full Text] [Related]
18. Adverse reactions to antipsychotics in Parkinson disease: an analysis of the Spanish pharmacovigilance database.
Lertxundi U; Ruiz AI; Aspiazu MÁ; Domingo-Echaburu S; García M; Aguirre C; García-Moncó JC
Clin Neuropharmacol; 2015; 38(3):69-84. PubMed ID: 25970275
[TBL] [Abstract][Full Text] [Related]
19. What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association.
Vilhelmsson A; Svensson T; Meeuwisse A; Carlsten A
BMC Clin Pharmacol; 2011 Oct; 11():16. PubMed ID: 22026961
[TBL] [Abstract][Full Text] [Related]
20. Signals of Adverse Drug Reactions Communicated by Pharmacovigilance Stakeholders: A Scoping Review of the Global Literature.
Sartori D; Aronson JK; Norén GN; Onakpoya IJ
Drug Saf; 2023 Feb; 46(2):109-120. PubMed ID: 36469249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
